Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN - Kinlough-Rathbone, R L; Perry, D W; Rand, M L; Packham, M A (Thromb Haemost, 1997)